NCT06981078 Phase 2 Active not recruiting
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD Study sponsor: Upstream Bio Inc. · UPB
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Changes Study details Primary completion 2027-10 Estimated
Enrollment · participants 666 Estimated
Source updated 2026-07-20 Last update listed in the registry record
Version history
Changes to this trial Last 12 months
This database covers selected trials and recorded edits. Some past edits may be missing, and saved text about the main study measures (endpoints) may be shortened. Check the original registry record when a detail matters. Read our methodology